Clear Search
·
11 MIN READ

Oct. 18, 2018: National Advocacy Update

Drug prices in TV ads, Surgeon General's opioid report and more in the latest AMA national health care advocacy news.

Advocacy Update
·
1 MIN READ

AMA on proposal to increase transparency in drug ads

While AMA is opposed to consumer advertising of prescription drugs, since the practice is allowed, ads should come with at least a small dose of transparency.

Press Releases
·
10 MIN READ

Oct. 4, 2018: National Advocacy Update

Doctor office drug compounding oversight, OPPS and ASC proposed rule and more in the latest AMA national health care advocacy news.

Advocacy Update
·
7 MIN READ

Sept. 20, 2018: National Advocacy Update

Opioid epidemic legislation, gag clause legislation and more in the latest AMA national health care advocacy news.

Advocacy Update
·
3 MIN READ

Sept. 6, 2018: National Advocacy Update

EHR quality metrics, federal background checks for firearms and more in the latest AMA national health care advocacy news.

Advocacy Update
·
3 MIN READ

Aug. 23, 2018: National Advocacy Update

Step therapy in Medicare Advantage plans, accountable care organizations and more in the latest AMA national health care advocacy news.

Advocacy Update
·
6 MIN READ

July 26, 2018: National Advocacy Update

Rural health clinics & repayment demands, drug shortages task force and more in the latest AMA national health care advocacy news.

Advocacy Update
·
1 MIN READ

AMA responds to administration blueprint to tackle rising drug prices

AMA sent the following letter in response to the Trump administration’s request for comments to its plan to lower drug prices.

Press Releases
·
3 MIN READ

AMA urges federal action to respond to insulin price hikes

With insulin prices spiking, the AMA urged the FTC and Justice Department to monitor insulin pricing and market competition.

Press Releases